TURNOVER (x1000 SEK)
NET PROFIT (x1000 SEK)
Biocontrol AS
Closing information (x1000 SEK)
Closing information | 2022/12 | 2021/12 | 2020/12 |
Turnover |
62,524
|
47,381
|
33,829 |
Financial expenses |
265
|
404
|
78 |
Earnings before taxes |
8,402
|
3,787
|
6,436 |
Total assets |
39,189
|
39,610
|
34,339 |
Current assets |
27,663
|
28,404
|
24,704 |
Current liabilities |
11,360
|
13,644
|
12,916 |
Equity capital |
27,828
|
25,966
|
21,423 |
- share capital |
2,724
|
2,642
|
2,460 |
Financial ratios
Fiscal year | 2022/12 | 2021/12 | 2020/12 |
Solvency |
71.0%
|
65.6%
|
62.4% |
Turnover per employee | |||
Profit as a percentage of turnover |
13.4%
|
8.0%
|
19.0% |
Return on assets (ROA) |
22.1%
|
10.6%
|
19.0% |
Current ratio |
243.5%
|
208.2%
|
191.3% |
Return on equity (ROE) |
30.2%
|
14.6%
|
30.0% |
Change turnover |
13,675
|
11,042
|
-14,352 |
Change turnover % |
28%
|
30%
|
-30% |
Chg. No. of employees | |||
Chg. No. of employees % |
Total value of public sale
Fiscal year | 2022/12 | 2021/12 | 2020/12 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.